本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

174.96
-1.5300-0.87%
盘后174.960.00000.00%17:23 EDT
成交量:38.73万
成交额:6,787.28万
市值:105.95亿
市盈率:-27.80
高:177.18
开:176.42
低:173.78
收:176.49
数据加载中...
2023/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/10

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/05

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals